The bilirubin blood test global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Bilirubin Blood Test Market, 2024The bilirubin blood test global market report 2024
Market Size –
The bilirubin blood test market size has grown strongly in recent years. It will grow from $1.26 billion in 2023 to $1.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the increasing prevalence of liver diseases, growth in neonatal care, technological advancements, rising health awareness, healthcare infrastructure development, regulatory approvals and guidelines, and increased adoption of point-of-care testing.
The bilirubin blood test market size is expected to see strong growth in the next few years. It will grow to $1.78 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growing demand for early diagnosis, expansion of diagnostic laboratories, rising incidence of chronic diseases, emerging markets growth, integration of advanced analytics, increased research funding. Major trends in the forecast period include development of non-invasive testing methods, integration with digital health solutions, advances in home testing kits, enhanced test accuracy and speed, personalized medicine approaches, smart diagnostic devices, development of portable devices.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report
Scope Of Bilirubin Blood Test Market
The Business Research Company’s reports encompass a wide range of information, including:
Bilirubin Blood Test Market Overview
Market Drivers –
The rising incidences of liver diseases are expected to contribute significantly to the growth of the bilirubin blood test market in the future. Liver diseases encompass various conditions that hinder the liver’s ability to function properly, resulting from diverse causes such as infections, alcohol abuse, or metabolic disorders. The growing prevalence of liver diseases can be linked to rising obesity rates, excessive alcohol consumption, viral infections, and unhealthy lifestyle choices that collectively contribute to liver dysfunction and damage. Bilirubin levels in the body are affected by liver disease, and bilirubin blood tests play a crucial role in diagnosing and monitoring liver function, offering essential insights into patient health and assisting healthcare providers in managing liver-related conditions effectively. For example, a report from the European Centre for Disease Prevention and Control in April 2024 revealed that there were 28,855 recorded cases of hepatitis B virus (HBV) infection across 30 EU/EEA Member States in 2022, reflecting a 78% increase compared to 16,187 cases in 2021. Therefore, the rising incidences of liver diseases are driving the growth of the bilirubin blood test market.
Market Trends –
Major companies operating in the bilirubin blood test market are adopting a strategic partnership approach to expand their reach and enhance their service offerings. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in December 2023, Calmark Sweden AB, an Israel-based medical diagnostic biotechnology solutions company, signed an exclusive distributor agreement with Techno Orbits in Saudi Arabia for Calmark’s bilirubin test designed for newborns. Techno Orbits will handle the distribution and sales of the product, leveraging its existing network and relationships, including with the Ministry of Health. This partnership aims to facilitate the introduction of Calmark’s bilirubin test into the Saudi market, where regulatory registration is expected to take 3 to 6 months.
The bilirubin blood test market covered in this report is segmented –
1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test
2) By Age Group: Adults, Pediatrics, Infants
3) By Application: Hospital, Clinic, Other Applications
Get an inside scoop of the bilirubin blood test market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp
Regional Insights –
North America was the largest region in the bilirubin blood test market in 2023. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies in the market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Drägerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.
Table of Contents
………..
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
……….
Table 74: F.Hoffmann-La Roche Ltd Financial Performance
Table 75: Thermo Fisher Scientific Inc. Financial Performance
Table 76: Abbott Laboratories Financial Performance
Table 77: Danaher Corporation Financial Performance
Table 78: Siemens Healthineers AG Financial Performance
Read Related Reports:
https://goodprnews.com/concentrated-nitric-acid-market-size-3/
https://topprnews.com/core-materials-market-growth/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The flat panel antenna global market report 2024 from The Business Research Company provides comprehensive…
The document verification global market report 2024 from The Business Research Company provides comprehensive market…
The consumer mobile payment global market report 2024 from The Business Research Company provides comprehensive…
The Mexico Antibody Drug Conjugates (ADC) market was valued at USD 390 million in 2023…
Artificial Intelligence (AI) Software Market, 2024 report by The Business Research Company offers comprehensive insights…
The Europe Furniture Market was valued at USD 216 billion in 2023 and is projected…